
WASHINGTON, May 15 (UPI) -- The U.S. Food and Drug Administration announced the Bayer Pharmaceuticals Corp. is removing its entire stock of the drug Trasylol from the U.S. market.
Last November Bayer agreed to an FDA-requested marketing suspension of Trasylol, a drug used to control bleeding during heart surgery. At that time, preliminary results from a Canadian study suggested the drug produced an increased risk of death compared with two similar drugs.
Now Bayer HealthCare Pharmaceuticals Inc. has notified the FDA it will remove all remaining Trasylol stock, most of which it said is in warehouses and hospitals' or physicians' stock, from the U.S. market.
Although the FDA said, while it hasn't received full study data from the Canadian researchers at the Ottawa Health Research Institute, it supports Bayer's decision.
|
|
|
|
|
|
| Additional Science News Stories | |
BAILIEBOROUGH, Ireland, May 27 (UPI) --
Two spectators were killed Sunday when a rally car at a race in Bailieborough, Ireland, crashed into a crowd on the side of a rural road, officials said.
|
CANNES, France, May 28 (UPI) --
Austrian director Michael Haneke's film "Amour" won the Cannes Film Festival's top prize, the Palme d'Or, officials said.
|
CAPE CANAVERAL, Fla., May 26 (UPI) --
Astronauts aboard the International Space Station have boarded the unmanned Dragon spacecraft and began unloading supplies, NASA TV showed.
|
Wedding parties told to quiet down ... Jersey falcons put up a squawk ... Man charged in drive-through gun incident ... iCloud sends pics of suspected phone thief ... Watercooler stories from UPI.
|
| Stories | Photos | People | Comments |
View Caption